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ABSTRACT 
Aim: This prospective cohort study investigated whether the use of preoperative 
anticoagulants is an independent risk factor for the outcomes of surgical treatment of 
patients with a neck of femur fracture. 
 
Methods: Data was obtained from a prospectively collected database. All patients 
admitted for a neck of femur fracture between Nov 2010 and Oct 2011 were included. This 
resulted in three hundred twenty-eight patients with 330 neck of femur fractures. Four 
groups were defined; patients preoperatively (i) on aspirin (n = 105); (ii) on clopidogrel (n 
= 28); (iii) on warfarin (n = 30); and (iv) without any anticoagulation history (n = 167, the 
control group). The non-warfarin group included the aspirin group, clopidogrel group 
and the control group. Primary outcome was the in-hospital mortality. Secondary 
outcomes were the postoperative complications, return to theatre and length of stay. 
 
Results: Thirteen in-hospital deaths were identified, 4 deaths in the aspirin group, 1 death 
in the clopidogrel group, 2 deaths in the warfarin group and 6 deaths in the control 
group. No significant difference in the mortality rates was found between the different 
groups. Also in the secondary outcomes, no significant difference was found between 
the four groups. A trend to a higher wound complication rate for the warfarin group was 
detected. 
 
Conclusion: The use of clopidrogel or aspirin pre operatively is not an influence on short 
term patient outcome for patients with a neck of femur fracture. Surgical procedures 
should not be delayed to reverse their influence. 
